Showing results (121-130 of 131) with videos related to
Sort By:
Pageof 14
Clinical Endoscopy|October 17, 2015
Indications for Detection, Completion, and Retention Rates of Small Bowel Capsule Endoscopy Based on the 10-Year Data from the Korean Capsule Endoscopy RegistryYun Jeong Lim, Oh Young Lee, Yoon Tae Jeen, et al.Gut and Liver|June 22, 2022
A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux DiseaseSu Hyun Park, Kang Nyeong Lee, Oh Young Lee, et al.Journal of Neurogastroenterology and Motility|January 28, 2014
Efficacy and Safety of Tiropramide in the Treatment of Patients With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-blind, Non-inferiority Trial, Compared With OctyloniumKang Nyeong Lee, Oh Young Lee, Myung-Gyu Choi, et al.Neurogastroenterology and Motility|November 26, 2024
Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi-Center, Randomized, Double-Blind, Active-Comparator Phase 4 TrialCheol Min Shin, Suck Chei Choi, Jin Woong Cho, et al.Journal of Korean Medical Science|September 30, 2017
Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority StudyYoon Jin Choi, Dong Ho Lee, Myung Gyu Choi, et al.Gut and Liver|February 15, 2023
Efficacy and Safety of Fexuprazan in Patients with Acute or Chronic GastritisGwang Ha Kim, Myung-Gyu Choi, Jin Il Kim, et al.World Journal of Gastroenterology|December 12, 2022
Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitisKang Nyeong Lee, Oh Young Lee, Hoon Jai Chun, et al.Alimentary Pharmacology & Therapeutics|October 31, 2022
Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitisYu Kyung Cho, Jae Hak Kim, Hyun-Soo Kim, et al.Alimentary Pharmacology & Therapeutics|March 8, 2019
Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitisKwang Jae Lee, Byoung Kwan Son, Gwang Ha Kim, et al.Journal of Neurogastroenterology and Motility|April 3, 2020
2019 Seoul Consensus on Esophageal Achalasia GuidelinesHye-Kyung Jung, Su Jin Hong, Oh Young Lee, et al.Pageof 14